Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012

Point of Care Diagnostics - Economic Reimbursement & Technology Trends

24 Oct 2012 - 25 Oct 2012 - London, UK

Bookmark and Share

SMi present their 9th annual Point of Care Diagnostics conference, which will bring together key members of the diagnostics and healthcare industries to discuss the implementation of technology, the reimbursements of the industry, and the connectivity of point of care technology throughout Europe and the world.

Benefits of Attending:

· Network with diagnostic manufacturers, pharmaceutical specialists and key healthcare practitioners working with POC technology

· Explore the economics, market developments, connectivity and the controversial topics of the POC industry

· Learn about the current market pulls and emerging technologies, and the ways they affect the medical diagnostics industry

· Discuss the POC industry, its potential expansion into wider markets and its future in the NHS and in European healthcare

· Consider new emerging technologies, and speak to the industry leaders at the forefront of development, manufacture and usage

Keynote Speakers include:

· Thomas Li, Senior Director, Technology Management, Roche Diagnostics, Singapore 

· Hans Winkler, Senior Director, Biomarkers, Janssen R&D (a Johnson & Johnson company) 

· David Huckle, President & Director General, ABA – France 

· Gilbert Greub, Chief of Medicine, Institute of Microbiology 

· Christopher Lowe, Director of the Institute of Biotechnology, University of Cambridge 


Tuesday 23rd of October, 2012, Copthorne Tara Hotel, London

A: Health economics, reimbursement, and market access for POC technologies

Workshop Leader: Kuo Tong, President & Founder, Quorum Consulting

8:30 – 12:30

B: The Future of Healthcare: Connecting the vision

Workshop leader: Simon Burnell, Partner, PA Consulting

13:30 – 17:30 pm

***Book before 31st May 2012 and save £300***

***Book before 29th June 2012 and save £100***

Visit our website here:

Alternatively Contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email:

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos